1 / 6

HER-2 Positive Breast Cancer Market in the US 2015-2019

Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated carcinoma. Breast cancer is the second most common form of cancer in women. HER-2 is a protein that affects the growth of malignant cells and is usually found on the surface of normal breast cells. Sometimes, a large number of HER-2 receptors are found on the surface of breast cancer cells. Get full report & TOC @: http://www.researchbeam.com/her-2-positive-breast-cancer-in-the-us-2015-2019-market

Florence_2012
Download Presentation

HER-2 Positive Breast Cancer Market in the US 2015-2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IT Services Market in Latin America 2015-2019Global Small Cell Lung Cancer Therapeutics Market 2015-2019Global Small Cell Lung Cancer Therapeutics Market 2015-2019HER-2 Positive Breast Cancer Market in the US 2015-2019 Industry Size, Share, Global Trends, Demand, Insights, Analysis, Research, Report, and Forecast2015- 2019 • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com

  2. Report overview Research Beam adds a report titled “HER-2 Positive Breast Cancer Market in the US 2015-2019” that provides latest market trends and opportunities. The report offers detailed analysis of the US HER-2 Positive Breast Cancer Industry. Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated carcinoma. Breast cancer is the second most common form of cancer in women. HER-2 is a protein that affects the growth of malignant cells and is usually found on the surface of normal breast cells. Sometimes, a large number of HER-2 receptors are found on the surface of breast cancer cells. These HER-2 receptors are responsible for stimulating the growth and division of malignant cancerous cells. This condition is therefore known as HER-2 positive breast cancer. HER-2 positive breast cancers have a tendency to spread and metastasize more rapidly than HER-2 negative breast cancers. HER-2 positive breast cancer is more prevalent in females than males. In 2012, GLOBOCAN reported that breast cancer accounted for 11.9 percent of the total number of cancer cases and led to 522,000 deaths worldwide. HER-2 positive breast cancer accounts for almost 25 percent of all types of breast cancer. As per the Report, The HER-2 Positive Breast Cancer market in US to grow at a CAGR of 12.65 percent over the period 2014-2019.

  3. Report overview Covered in this Report This report covers the present scenario and the growth prospects of the HER-2 Positive Breast Cancer market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of targeted therapeutics and chemotherapeutics used in the management of HER-2 positive breast cancer patients. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the HER-2 Positive Breast Cancer market in the US. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. HER-2 Positive Breast Cancer Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the HER-2 Positive Breast Cancer market in the US and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key Vendors • Celgene • F. Hoffmann-La Roche • GlaxoSmithKline • Novartis • Sanofi

  4. Report overview Market Driver • Increase in Population of Breast Cancer Patients • For a full, detailed list, view our report Market Challenge • Poor Diagnosis and Screening • For a full, detailed list, view our report Market Trend • Increase in Awareness • For a full, detailed list, view our report Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Enquire about report @: http://www.researchbeam.com/her-2-positive-breast-cancer-in-the-us-2015-2019-market/enquire-about-report

  5. Table of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Disease Overview 07. Market Landscape 08. Market Segmentation by Type of Therapy 09. 9 Market Segmentation by Molecule Type 10 Market Segmentation by Route of Administration 11 Buying Criteria 12 Market Growth Drivers 13 Drivers and their Impact 14 Market Challenges 15 Impact of Drivers and Challenges 16 Market Trends 17 Trends and their Impact 18 Vendor Landscape 19 Key Vendor Analysis 20 Other Reports in this Series

  6. FOR MORE DETAILS Visit us at : http://www.researchbeam.com/her-2-positive-breast-cancer-in-the-us-2015-2019-market • TELEPHONE: +1 (855) 711-1555E-MAIL: sales@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States Stay With Us:

More Related